A therapeutic study comparing the association of rifampin, ofloxacin and minocycline with the association of rifampin, clofazimine and dapsone in multibacillary leprosy patients

A therapeutic study comparing the association of rifampin, ofloxacin and minocycline with the association of rifampin, clofazimine and dapsone in multibacillary leprosy patients

Bibliographic Details
Main Author:	Ura Somei
Format:	Article
Language:	English
Published:	SciELO 2007-01-01
Series:	Journal of Venomous Animals and Toxins including Tropical Diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992007000100011

Similar Items

Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
by: Paul J Converse, et al.
Published: (2015-01-01)

Adverse reactions induced by MDT/WHO (Rifampicin+Clofazimine+Dapsone) and ROM (Rifampicin+Ofloxacin+Minocycline) regimens used in the treatment of leprosy: a cohort study in a National Reference Center in Brazil
by: Isadora Costa Celestino, et al.
Published: (2024-03-01)

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
by: Shannon M Lenz, et al.
Published: (2020-09-01)

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy
by: Shannon M. Lenz, et al.
Published: (2020-09-01)

Etymologia: Rifampin
by: Ronnie Henry
Published: (2018-03-01)

Increased hepcidin expression in multibacillary leprosy
by: Vânia Nieto Brito de Souza, et al.
Published: (2012-12-01)

Novel approaches in the treatment of Hansen’s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States
by: Carlos Franco-Paredes, et al.
Published: (2022-11-01)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
by: Sirous M, et al.
Published: (2018-10-01)

Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
by: Huang YT, et al.
Published: (2018-08-01)

Pharmacodynamic biomarkers for quantifying the mycobacterial effect of high doses of rifampin in patients with rifampin-susceptible pulmonary tuberculosis
by: Bibie N Said, et al.
Published: (2021-01-01)

Rifampin-resistant Meningococcal Disease
by: Jean Rainbow, et al.
Published: (2005-06-01)

Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis
by: Rasoul Mirzaei, et al.
Published: (2022-06-01)

Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance
by: Ali Darwich, et al.
Published: (2021-09-01)

Comparison of Efficacy and Safety of Doxycycline + Rifampin Combination Versus Rifampin + Trimethoprim-Sulfamethoxazole Combination in the Treatment of Brucellosis
by: Ayşe ERBAY, et al.
Published: (2002-03-01)

Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India
by: Mallika Lavania, et al.
Published: (2020-12-01)

Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
by: Ameeta S. Kalokhe, et al.
Published: (2012-03-01)

Deranged Haemostasis: Rifampin-Induced Coagulopathy
by: Raghu Tiperneni, et al.
Published: (2022-05-01)

A randomized, comparative study of dual therapy (doxycycline–rifampin) versus triple therapy (doxycycline–rifampin–levofloxacin) for treating acute/subacute brucellosis
by: Ahmad Hasanain, et al.
Published: (2016-05-01)

Avaliação de hansenianos tratados com esquema alternativo dose única ROM (rifampicina, ofloxacina e minociclina), após sete a nove anos Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine
by: Lucia Martins Diniz, et al.
Published: (2010-12-01)

Multibacillary Leprosy in a Child
by: Min Wang, et al.
Published: (2018-01-01)

Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis
by: Min Hong Ki, et al.
Published: (2013-01-01)

Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, Brazil Efeitos adversos das drogas (minociclina, ofloxacina e clofazimina) utilizadas no esquema alternativo para pacientes com hanseníase multibacilar, em unidade de referência, Manaus, Amazonas, Brasil
by: Marina Valente Maia, et al.
Published: (2013-04-01)

Antimalarial effects of rifampin in Plasmodium vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (1994)

Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin
by: Pengfei She, et al.
Published: (2022-12-01)

Mycobacterium tuberculosis and Rifampin Resistance, United Kingdom
by: I-Ching Sam, et al.
Published: (2006-05-01)

Gene expression patterns associated with multidrug therapy in multibacillary leprosy
by: Helen Ferreira, et al.
Published: (2022-07-01)

Association of MBL2 Exon 1 Polymorphisms With Multibacillary Leprosy
by: Bruna Tiaki Tiyo, et al.
Published: (2020-09-01)

Coxiella burnetti prosthetic joint infection in an immunocompromised woman: iterative surgeries, prolonged ofloxacin-rifampin treatment and complex reconstruction were needed for the cure
by: Patrick Miailhes, et al.
Published: (2021-12-01)

Blood coagulation abnormalities in multibacillary leprosy patients.
by: Débora Santos da Silva, et al.
Published: (2018-03-01)

Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases
by: Madhvi Ahuja, et al.
Published: (2022-09-01)

Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy.
by: Diana N J Lockwood, et al.
Published: (2012-01-01)

Unusual Presentation of Multibacillary Nodular Leprosy
by: Shweta Raut, et al.
Published: (2017-01-01)

Frequent testicular involvement in multibacillary leprosy
by: Hendra Gunawan, et al.
Published: (2020-01-01)

Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients
by: Levin Thomas, et al.
Published: (2020-06-01)

Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients
by: Jolly Kuriakose, et al.
Published: (2022-06-01)

Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication.
by: Hye In Kim, et al.
Published: (2017-01-01)

Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?
by: Nora Renz, et al.
Published: (2021-02-01)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
by: Elsje Pienaar, et al.
Published: (2018-01-01)

Rifampin resistance and its fitness cost in Riemerella anatipestifer
by: Jiakai Sun, et al.
Published: (2019-05-01)

Efficacy of Co-trimoxazol and Rifampine in treatment of childhood Brucellosis
by: MR Hassanjani Roshan, et al.
Published: (2000-10-01)